Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy a committee opinion

This document describes the responsibilities and strategies for fertility preservation in patients undergoing gonadotoxic medical therapy or radiation therapy or gonadectomy.

Like Comment

Authors

The Practice Committee of the American Society for Reproductive Medicine

Volume 100, Issue 5, Pages 1214-1223, November 2013

Abstract

Patients preparing to undergo gonadotoxic medical therapy or radiation therapy or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)02957-9/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.